Results 81 to 90 of about 192,096 (187)

Individualized antisense oligonucleotide treatment eligibility of patients living with neurodevelopmental diseases. [PDF]

open access: yesCell Rep Med
Aartsma-Rus A   +9 more
europepmc   +1 more source

Prostate Cancer Patient-Derived Organoids (PDOs) as Functional Avatars for Antisense Oligonucleotide (ASO)-Based Personalized Therapy. [PDF]

open access: yesAdv Healthc Mater
Tran TT   +15 more
europepmc   +1 more source

Targeting the lung using siRNA and antisense based oligonucleotides

open access: yes, 2008
The accessibility to topical administration through inhalation, combined with its large surface area, has led to speculation that the lung might offer an ideal target for the application of oligonucleotide based therapeutics.
Williams, A.E.   +3 more
core  

Accurately modeling RNase H-mediated antisense oligonucleotide efficacy. [PDF]

open access: yesMol Ther Nucleic Acids
Hill B   +9 more
europepmc   +1 more source

Gene-Specific Antisense Oligonucleotide Therapy Targeting AMA1: A Potential Malaria Treatment. [PDF]

open access: yesIran J Parasitol
Hanifian H   +6 more
europepmc   +1 more source

Development of an antisense oligonucleotide targeting EFEMP1 in models relevant to macular degeneration. [PDF]

open access: yesMol Ther Nucleic Acids
Miller WP   +26 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy